% Viability and standard deviation of isolated compounds against HepG2 cancer.

Sample	% Viability
Chrysophanol (12)	59.32 ± 2.20
Physine (13)	87.44 ± 2.55
β-Sitosterol 3-O-β-d-glucopyranoside (16)	96.40 ± 2.20
Luteolin (2)	82.46 ± 4.31
β-Sitosterol (15)	94.44 ± 4.42
Stigmat-4-en-3,6-dione (9)	31.13 ± 2.68
Stigmast-4-en-3β,6α-diol (10)	14.47 ± 0.68
Emodin (11)	83.89 ± 0.73
Apigenin-8-C-β-d-glucopyranoside (5)	94.67 ± 7.40
Lutéolin-8-C-β-d-glucopyranoside (6)	89.23 ± 2.50
Luteolin-5-methyl ether (4)	90.55 ± 2.15
Luteolin-6-C-β-d-glucopyranoside (7)	97.94 ± 3.53